clarithromycin has been researched along with Leukemia, Acute Monocytic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Gomi, K; Hagiwara, K; Honda, Y; Kikuchi, T; Kobayashi, T; Nukiwa, T; Takahashi, H; Tokue, Y; Watanabe, A | 1 |
1 other study(ies) available for clarithromycin and Leukemia, Acute Monocytic
Article | Year |
---|---|
Clarithromycin suppresses lipopolysaccharide-induced interleukin-8 production by human monocytes through AP-1 and NF-kappa B transcription factors.
Topics: Anti-Bacterial Agents; Clarithromycin; Depression, Chemical; Escherichia coli; Humans; Indicators and Reagents; Interleukin-8; Leukemia, Monocytic, Acute; Lipopolysaccharides; Luciferases; Monocytes; NF-kappa B; Nuclear Proteins; Pancreatitis-Associated Proteins; Plasmids; RNA, Messenger; Transcription Factor AP-1; Transfection; Tumor Cells, Cultured | 2002 |